首页> 外文OA文献 >Which treatment is preferred for advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor in second-line therapy? A meta-analysis comparing immune checkpoint inhibitor, tyrosine kinase inhibitor and chemotherapy

【2h】

Which treatment is preferred for advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor in second-line therapy? A meta-analysis comparing immune checkpoint inhibitor, tyrosine kinase inhibitor and chemotherapy

机译：在二线治疗中具有野生型表皮生长因子受体的晚期非小细胞肺癌优选哪种处理？比较免疫检查点抑制剂，酪氨酸激酶抑制剂和化疗的荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Di Wu; Chongyang Duan; Fenfang Wu; Liyong Chen; Size Chen;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of epidermal growth factor receptor inhibitors versus chemotherapy as second-line treatment in advanced non-small-cell lung cancer with wild-type EGFR: A meta-analysis of randomized controlled clinical trials [J] . ZhaoN., ZhangX.-C., YanH.-H., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2014,第1期

机译：表皮生长因子受体抑制剂与化学疗法作为野生型EGFR晚期非小细胞肺癌二线治疗的疗效：一项随机对照临床试验的荟萃分析
2. Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non-small cell lung cancer harboring wild-type epidermal growth factor receptor: A meta-analysis [J] . LeeJ.-K., HahnS., KimD.-W., JAMA: the Journal of the American Medical Association . 2014,第14期

机译：表皮生长因子受体酪氨酸激酶抑制剂与非小细胞肺癌的常规化疗，含有野生型表皮生长因子受体：META分析
3. Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non-small cell lung cancer harboring wild-type epidermal growth factor receptor: A meta-analysis [J] . LeeJ.-K., HahnS., KimD.-W., JAMA: the Journal of the American Medical Association . 2014,第14期

机译：表皮生长因子受体酪氨酸激酶抑制剂与常规化学疗法治疗非小细胞肺癌野生型表皮生长因子受体的荟萃分析
4. QSAR Study of Quinazoline Derivatives as Inhibitor of Epidermal Growth Factor Receptor-Tyrosine Kinase (EGFR-TK) [C] . La Ode Aman, Widisusanti Abdulkadir, Julitha Geybie Rembet, International Conference on Computation for Science and Technology . 2015

机译：喹唑啉衍生物作为表皮生长因子受体 - 酪氨酸激酶（EGFR-TK）抑制剂的QSAR研究
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Which treatment is preferred for advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor in second-line therapy? A meta-analysis comparing immune checkpoint inhibitor tyrosine kinase inhibitor and chemotherapy [O] . Di Wu, Chongyang Duan, Fenfang Wu, 2017

机译：在二线治疗中对于具有野生型表皮生长因子受体的晚期非小细胞肺癌首选哪种治疗方法？免疫检查点抑制剂酪氨酸激酶抑制剂和化学疗法比较的荟萃分析
7. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor [O] . June-Koo Lee, Seokyung Hahn, Dong-Wan Kim, 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂与含有野生型表皮生长因子受体的非小细胞肺癌常规化疗

Which treatment is preferred for advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor in second-line therapy? A meta-analysis comparing immune checkpoint inhibitor, tyrosine kinase inhibitor and chemotherapy

著录项

相似文献

相关主题

期刊订阅